Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 10

1.

In vitro activity of linezolid against slowly growing nontuberculous Mycobacteria.

Brown-Elliott BA, Crist CJ, Mann LB, Wilson RW, Wallace RJ Jr.

Antimicrob Agents Chemother. 2003 May;47(5):1736-8.

2.

Resistance mechanisms and drug susceptibility testing of nontuberculous mycobacteria.

van Ingen J, Boeree MJ, van Soolingen D, Mouton JW.

Drug Resist Updat. 2012 Jun;15(3):149-61. doi: 10.1016/j.drup.2012.04.001. Epub 2012 Apr 21. Review.

PMID:
22525524
3.

Treatment of slowly growing mycobacteria.

Philley JV, Griffith DE.

Clin Chest Med. 2015 Mar;36(1):79-90. doi: 10.1016/j.ccm.2014.10.005. Epub 2014 Nov 6. Review.

PMID:
25676521
4.

Antimycobacterial activities of oxazolidinones: a review.

Sood R, Bhadauriya T, Rao M, Gautam R, Malhotra S, Barman TK, Upadhyay DJ, Rattan A.

Infect Disord Drug Targets. 2006 Dec;6(4):343-54. Review.

PMID:
17168800
5.

Drug susceptibility testing of nontuberculous mycobacteria.

van Ingen J, Kuijper EJ.

Future Microbiol. 2014;9(9):1095-110. doi: 10.2217/fmb.14.60. Review.

PMID:
25340838
6.

Drug treatment of pulmonary nontuberculous mycobacterial disease in HIV-negative patients: the evidence.

van Ingen J, Ferro BE, Hoefsloot W, Boeree MJ, van Soolingen D.

Expert Rev Anti Infect Ther. 2013 Oct;11(10):1065-77. doi: 10.1586/14787210.2013.830413. Review.

PMID:
24124798
7.

Nontuberculous mycobacteria in respiratory infections: advances in diagnosis and identification.

Somoskovi A, Salfinger M.

Clin Lab Med. 2014 Jun;34(2):271-95. doi: 10.1016/j.cll.2014.03.001. Review.

PMID:
24856528
8.

Antimicrobial susceptibility testing, drug resistance mechanisms, and therapy of infections with nontuberculous mycobacteria.

Brown-Elliott BA, Nash KA, Wallace RJ Jr.

Clin Microbiol Rev. 2012 Jul;25(3):545-82. doi: 10.1128/CMR.05030-11. Review.

9.

Current treatment of nontuberculous mycobacteriosis: an update.

Esteban J, García-Pedrazuela M, Muñoz-Egea MC, Alcaide F.

Expert Opin Pharmacother. 2012 May;13(7):967-86. doi: 10.1517/14656566.2012.677824. Review.

PMID:
22519767
10.

Challenges facing the drug discovery pipeline for non-tuberculous mycobacteria.

Soni I, De Groote MA, Dasgupta A, Chopra S.

J Med Microbiol. 2016 Jan;65(1):1-8. doi: 10.1099/jmm.0.000198. Epub 2015 Oct 29. Review.

PMID:
26515915

Supplemental Content

Support Center